MEREDITH SIEVERS: Open Payments
NPI 1265157531 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 23 payments from 10 companies in 2025. Trend: 2023 $570 · 2024 $527 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $172 |
| E.R. Squibb & Sons, L.L.C. | 1 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
Products named: INGREZZA, COBENFY, CAPLYTA, FANAPT, Jornay PM, INVEGA SUSTENNA, REXULTI, Auvelity.
Industry payments across ID — which companies pay providers there.
